top of page
The TRanslational Initiative to DE-Risk Therapeutics
Hot off the press! Check out the latest edition of the TRIDENT e-newsletter, linked HERE!
The TRanslational Initiative to DErisk NeuroTherapeutic (TRIDENT) draws upon research supported by the Government of Canada’s New Frontiers in Research Fund (NFRF).
Le TRanslational Initiative to DErisk NeuroTherapeutic (TRIDENT) repose sur des recherches financées par le fonds Nouvelles frontières en recherche dugouvernement du Canada.
By offering a transformative approach to preclinical evaluation of neurotherapeutics, TRIDENT will dramatically improve the odds of success of neurotherapeutics in clinical trials for the benefit of humans across the globe.
One Platform.
3 Integrated Model Systems.
Contact Us
Leading Partner
Collaboration
.png)
.png){kind=logo}
.png)
_edited.png)
bottom of page